Scott, Mike A

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet

Myeloproliferative Neoplasms: Diagnosis and TreatmentPlatelet Disorders and Treatments

Cited by 3,548

Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis

McKerrell, T., Park, N., Moreno, T., Grove, C. S., Ponstingl, H., Stephens, J., Crawley, C., Craig, J., Scott, M. A., Hodkinson, C., et al. (2015) · Cell Reports

Acute Myeloid Leukemia ResearchCancer Genomics and Diagnostics

Cited by 534

Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen

Bord, S., Frith, E., Ireland, D. C., Scott, M. A., Craig, J. I. O., & Compston, J. E. (2004) · British Journal of Haematology

Bone Metabolism and DiseasesPlatelet Disorders and Treatments

Cited by 56